Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
The lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.
To increase the amount of syphilis testing, labs need to remove moral judgement and acknowledge the STI as just another infection.
CAP developed recommendations for testing immunotherapy biomarkers, such as PD-L1 and TM), in patients with NSCLC.
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Agilent Technologies announced that its GenetiSure Dx Postnatal Assay received European IVDR Class C Certification.
The emerging Powassan virus in ticks can cause life-threatening neuroinvasive disease, including encephalitis and meningitis.
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Labcorp's new blood test detects glial fibrillary acidic protein, a crucial biomarker for identifying neurodegenerative diseases.
A blood test could potentially be used to assess a patient’s risk of type 2 diabetes, a new study from Edith Cowan University has found.
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
The Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.